CEO Makes Bold Move with Major Stock Purchase in Cassava Sciences

New insider activity at Cassava Sciences ( (SAVA) ) has taken place on September 22, 2025.

President & CEO Richard Barry has made a significant investment in Cassava Sciences by purchasing 237,941 shares of the company’s stock. This transaction is valued at $534,743, showcasing Barry’s confidence in the company’s future prospects.

Recent Updates on SAVA stock

Cassava Sciences has recently released a corporate presentation, which is part of a Form 8-K filing but not subject to the liabilities of the Securities Exchange Act of 1934. The latest analyst rating for Cassava Sciences is a Hold with a price target of $2.00. The company is facing significant financial challenges, including no revenue and ongoing operational losses, which are reflected in its low financial performance score and bearish technical indicators. The negative P/E ratio highlights valuation concerns. Despite these challenges, a strategic license agreement with Yale University could offer future growth potential, although it is currently considered speculative. The technical sentiment signal for Cassava Sciences is a Sell, and it has a market cap of $104.3 million.

Spark’s Take on SAVA Stock

According to Spark, TipRanks’ AI Analyst, SAVA is a Neutral.

Cassava Sciences faces significant financial challenges with no revenue and ongoing operational losses, reflected in the low financial performance score. Technical indicators show bearish trends, and the negative P/E ratio emphasizes valuation concerns. However, the strategic license agreement with Yale University could offer future growth potential, though it currently holds minimal weight due to its speculative nature.

To see Spark’s full report on SAVA stock, click here.

More about Cassava Sciences

YTD Price Performance: -17.09%

Average Trading Volume: 845,949

Technical Sentiment Signal: Sell

Current Market Cap: $110.1M